Search

everythinglearnresearchcommunity

for

Search:↓

Researchers found 63 genes linked to male-pattern baldness, which could help in understanding its biology and developing new treatments.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Finasteride helps hair growth by decreasing cell death in hair follicles.

Hormonal therapies help treat female hair loss, but results are slow and vary.

Finasteride affects hair growth by changing caspase and XIAP levels, potentially treating hair diseases.

Hormonal changes during and after pregnancy can cause hair growth changes and hair loss, with treatments available for some conditions.

Finasteride treatment changes urine metabolomics and steroid signatures, potentially monitoring effectiveness but may cause sexual side effects.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

Minoxidil was more effective than laser therapy for hair loss, and the report also highlighted the need for more research on PRP for a different hair loss condition, the impact of social media on alopecia views, and a warning on turmeric causing nail discoloration.

Some cosmetic procedures show promise for treating hair loss, but more research is needed to confirm their safety and effectiveness.

The Free Androgen Index (FAI) is the best indicator of early hair loss in men before age 30.

Men with early hair loss may have a higher risk of enlarged prostate and possibly prostate cancer due to shared hormonal factors.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Nanostructured delivery systems could potentially improve hair loss treatment by targeting drugs to hair follicles, reducing side effects and dosage, but the best size, charge, and materials for these systems need further investigation.

Oxidative stress plays a significant role in alopecia areata, and new treatments may include JAK inhibitors and antioxidants.

Chitosan-decorated finasteride nanosystems improve skin retention and could be a better treatment for hair loss.

Combination therapies for androgenetic alopecia work best but can have significant side effects and costs.

Finasteride and dutasteride are effective in treating male hair loss but can cause sexual side effects and birth defects.

The document concludes that personalized treatment plans for hair loss in Asian men are necessary and more research is needed to develop effective guidelines.

Minoxidil 2% and 5% are common treatments for female pattern hair loss, with other options including anti-androgens, oral contraceptives, and hair transplantation.

Understanding how androgens and their receptors work can lead to improved treatments for skin diseases.

Hair loss can be managed with treatments like minoxidil, finasteride, and others, but there are still gaps in effectiveness and off-label usage is increasing.

A woman's skin darkened after using dutasteride and pimecrolimus for hair loss, but improved when she stopped the medications and protected her skin from light.

One Ashwagandha extract may help protect cells with its antioxidant properties, while another could promote hair growth.

The Trust tonic is more effective than minoxidil for treating hair loss.

The treatment led to denser, thicker hair growth and less hair loss.

Finasteride treatment for three years changes certain polyamine levels in the blood but not in urine.

Dutasteride 0.5mg was found to be more effective than finasteride 1mg in treating male pattern hair loss, with similar side effects.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Finasteride may cause sexual side effects like erectile dysfunction, but they are reversible and affect less than 2% of men.